TrialAmerican journal of hematology2014

A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia.

Michael J Burke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.